Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


David Ridley

Senior Editor – Europe

During his time at OTC bulletin, David focused mainly on the European OTC market, especially German-speaking countries: Germany, Austria and Switzerland). David is interested in European OTC, herbal/homeopathic, food supplement and self-care medical device regulation, and prescription-to-OTC switches in particular. Before working for OTC bulletin, David was a Lecturer in English and Journalism, and alongside his job David moonlights as a musician in a heavy metal band.
Set Alert for Articles By David Ridley

Latest From David Ridley

Lithuanian Liberalization ‘Justified,’ Says Vice-Minister of Health

A rush of retailers signing up to sell OTC medicines has suggested that Lithuania's decision to liberalize its OTC market was 'justified,' according to the country's Vice-Minister of Health Kristina Garuolienės. 
Health Regulation

Health Marketing Round-Up: January 2019

New OTC products and marketing campaigns in Germany, Australia and the UK.
Health OTC Drugs

NHS 10-Year Plan A ‘Missed Opportunity’, Says PAGB

The UK’s consumer healthcare industry association, the Proprietary Association of Great Britain (PAGB), says that National Health Service (NHS) England has “missed an opportunity” by not placing self-care at the center of its new ‘Long Term Plan’.

Health Regulation

EllaOne Firm Endorses UK Reproductive Rights Group's Push For OTC Sales Of Emergency Contraceptives

EllaOne manufacturer HRA Pharma supports British Pregnancy Advisory Service's call to scrap mandatory consultations for emergency contraceptives by switching the medicines from pharmacy-only sales to OTC. BPAS says there are “no risks which outweigh its use and it is considerably safer than many medicines sold straight from the shelf in the UK."

Consumer Prescription To Otc Switch

Starpharma’s Innovative VivaGel Condom Ready For Launch in Japan

Starpharma has received approval for its innovative VivaGel condom in Japan, which will be launched in the first half of 2019 by Okamoto Industries. 
OTC Devices Launches

Make Emergency Contraceptives GSL In The UK, Urge HRA Pharma And The British Pregnancy Advisory Service

EllaOne manufacturer HRA Pharma supports the British Pregnancy Advisory Service's (BPAS') calls to scrap mandatory consultations for emergency contraceptives by switching these medicines from pharmacy-only to general sales list status. 
Health OTC Drugs
See All